Literature DB >> 24100018

NF-κB1 inhibits NOD2-induced cytokine secretion through ATF3-dependent mechanisms.

Shasha Zheng1, Clara Abraham.   

Abstract

Regulation of microbially induced cytokine secretion is critical in intestinal immune homeostasis. NOD2, the Crohn's disease-associated bacterial peptidoglycan sensor, activates the NF-κB pathway. After chronic NOD2 stimulation in human macrophages, cytokine secretion is significantly attenuated, similar to the situation in the intestinal environment. We find that NF-κB1 (p105/p50) expression is upregulated with chronic NOD2 stimulation and is required for attenuation of cytokine secretion in vitro in human macrophages and in vivo in mice. Upon chronic NOD2 stimulation, regulation of both activating (H3K4Me2 and H4Ac) and inhibitory (H3K27Me3) histone modifications was observed within cytokine gene promoters; these outcomes were NF-κB1 dependent. In addition to enhanced binding to cytokine gene promoters with chronic NOD2 stimulation, NF-κB1 bound to the promoter of the transcriptional repressor, ATF3. ATF3 was then induced and bound to cytokine gene promoters; both features were impaired upon NF-κB1 knockdown. Restoring ATF3 expression under NF-κB1 knockdown conditions restored NOD2-mediated cytokine downregulation. Finally, NF-κB1 and ATF3 cooperate with other inhibitory pathways, including IRAKM and secreted mediators, to downregulate cytokine secretion after chronic NOD2 stimulation. Therefore, we identify NF-κB1 and ATF3 as critical mechanisms through which NOD2 downregulates cytokines and contributes to intestinal immune homeostasis.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24100018      PMCID: PMC3889551          DOI: 10.1128/MCB.00797-13

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  52 in total

1.  IL-12 suppression during experimental endotoxin tolerance: dendritic cell loss and macrophage hyporesponsiveness.

Authors:  M Wysocka; S Robertson; H Riemann; J Caamano; C Hunter; A Mackiewicz; L J Montaner; G Trinchieri; C L Karp
Journal:  J Immunol       Date:  2001-06-15       Impact factor: 5.422

2.  Negative regulation of toll-like receptor-mediated signaling by Tollip.

Authors:  Guolong Zhang; Sankar Ghosh
Journal:  J Biol Chem       Date:  2001-12-18       Impact factor: 5.157

3.  NLRP1 and NLRP3 inflammasomes are essential for distinct outcomes of decreased cytokines but enhanced bacterial killing upon chronic Nod2 stimulation.

Authors:  Matija Hedl; Clara Abraham
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2013-01-03       Impact factor: 4.052

4.  A role for NF-kappa B subunits p50 and p65 in the inhibition of lipopolysaccharide-induced shock.

Authors:  Mihaela Gadjeva; Michal F Tomczak; Ming Zhang; Yan Yan Wang; Karen Dull; Arlin B Rogers; Susan E Erdman; James G Fox; Michael Carroll; Bruce H Horwitz
Journal:  J Immunol       Date:  2004-11-01       Impact factor: 5.422

5.  Regulation of IL-8 and IL-1beta expression in Crohn's disease associated NOD2/CARD15 mutations.

Authors:  Jing Li; Thomas Moran; Eric Swanson; Christina Julian; Jeremy Harris; Denise K Bonen; Matija Hedl; Dan L Nicolae; Clara Abraham; Judy H Cho
Journal:  Hum Mol Genet       Date:  2004-06-15       Impact factor: 6.150

6.  Induction of in vitro reprogramming by Toll-like receptor (TLR)2 and TLR4 agonists in murine macrophages: effects of TLR "homotolerance" versus "heterotolerance" on NF-kappa B signaling pathway components.

Authors:  Marina A Dobrovolskaia; Andrei E Medvedev; Karen E Thomas; Natalia Cuesta; Vladimir Toshchakov; Tianbo Ren; Michael J Cody; Suzanne M Michalek; Nancy R Rice; Stefanie N Vogel
Journal:  J Immunol       Date:  2003-01-01       Impact factor: 5.422

7.  NOD2 is a negative regulator of Toll-like receptor 2-mediated T helper type 1 responses.

Authors:  Tomohiro Watanabe; Atsushi Kitani; Peter J Murray; Warren Strober
Journal:  Nat Immunol       Date:  2004-06-27       Impact factor: 25.606

8.  Host recognition of bacterial muramyl dipeptide mediated through NOD2. Implications for Crohn's disease.

Authors:  Naohiro Inohara; Yasunori Ogura; Ana Fontalba; Olga Gutierrez; Fernando Pons; Javier Crespo; Koichi Fukase; Seiichi Inamura; Shoichi Kusumoto; Masahito Hashimoto; Simon J Foster; Anthony P Moran; Jose L Fernandez-Luna; Gabriel Nuñez
Journal:  J Biol Chem       Date:  2003-01-04       Impact factor: 5.157

9.  Functional annotation of a novel NFKB1 promoter polymorphism that increases risk for ulcerative colitis.

Authors:  Amir S Karban; Toshihiko Okazaki; Carolien I M Panhuysen; Thomas Gallegos; James J Potter; Joan E Bailey-Wilson; Mark S Silverberg; Richard H Duerr; Judy H Cho; Peter K Gregersen; Yuqiong Wu; Jean-Paul Achkar; Themistocles Dassopoulos; Esteban Mezey; Theodore M Bayless; Franklin J Nouvet; Steven R Brant
Journal:  Hum Mol Genet       Date:  2003-11-12       Impact factor: 6.150

10.  Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection.

Authors:  Stephen E Girardin; Ivo G Boneca; Jérôme Viala; Mathias Chamaillard; Agnès Labigne; Gilles Thomas; Dana J Philpott; Philippe J Sansonetti
Journal:  J Biol Chem       Date:  2003-01-13       Impact factor: 5.157

View more
  18 in total

1.  TAM receptor-dependent regulation of SOCS3 and MAPKs contributes to proinflammatory cytokine downregulation following chronic NOD2 stimulation of human macrophages.

Authors:  Shasha Zheng; Matija Hedl; Clara Abraham
Journal:  J Immunol       Date:  2015-01-07       Impact factor: 5.422

2.  Twist1 and Twist2 Induce Human Macrophage Memory upon Chronic Innate Receptor Treatment by HDAC-Mediated Deacetylation of Cytokine Promoters.

Authors:  Rui Sun; Matija Hedl; Clara Abraham
Journal:  J Immunol       Date:  2019-04-26       Impact factor: 5.422

Review 3.  Genetic and epigenetic regulation of intestinal fibrosis.

Authors:  Chao Li; John F Kuemmerle
Journal:  United European Gastroenterol J       Date:  2016-07-14       Impact factor: 4.623

4.  STAT3 and STAT5 Signaling Thresholds Determine Distinct Regulation for Innate Receptor-Induced Inflammatory Cytokines, and STAT3/STAT5 Disease Variants Modulate These Outcomes.

Authors:  Matija Hedl; Rui Sun; Chen Huang; Clara Abraham
Journal:  J Immunol       Date:  2019-11-15       Impact factor: 5.422

5.  T Cell-Intrinsic IRF5 Regulates T Cell Signaling, Migration, and Differentiation and Promotes Intestinal Inflammation.

Authors:  Jie Yan; Surya P Pandey; Betsy J Barnes; Jerrold R Turner; Clara Abraham
Journal:  Cell Rep       Date:  2020-06-30       Impact factor: 9.423

6.  Pivotal role of NOD2 in inflammatory processes affecting atherosclerosis and periodontal bone loss.

Authors:  Huaiping Yuan; Sami Zelkha; Sami Zelka; Marina Burkatovskaya; Rohit Gupte; Susan E Leeman; Salomon Amar
Journal:  Proc Natl Acad Sci U S A       Date:  2013-12-09       Impact factor: 11.205

7.  JAK2 Disease-Risk Variants Are Gain of Function and JAK Signaling Threshold Determines Innate Receptor-Induced Proinflammatory Cytokine Secretion in Macrophages.

Authors:  Matija Hedl; Deborah D Proctor; Clara Abraham
Journal:  J Immunol       Date:  2016-09-23       Impact factor: 5.422

8.  An inflammatory bowel disease-risk variant in INAVA decreases pattern recognition receptor-induced outcomes.

Authors:  Jie Yan; Matija Hedl; Clara Abraham
Journal:  J Clin Invest       Date:  2017-04-24       Impact factor: 14.808

9.  Activation of pattern recognition receptors up-regulates metallothioneins, thereby increasing intracellular accumulation of zinc, autophagy, and bacterial clearance by macrophages.

Authors:  Amit Lahiri; Clara Abraham
Journal:  Gastroenterology       Date:  2014-06-21       Impact factor: 22.682

10.  Myeloid Cell-Intrinsic IRF5 Promotes T Cell Responses through Multiple Distinct Checkpoints In Vivo, and IRF5 Immune-Mediated Disease Risk Variants Modulate These Myeloid Cell Functions.

Authors:  Jie Yan; Matija Hedl; Clara Abraham
Journal:  J Immunol       Date:  2020-07-20       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.